Clinical Trial Update: Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating Spectra Optia Red Blood Cell Exchange in patients with Sickle Cell Disease; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Spectra Optia Red Blood Cell Exchange

Snippet

Sponsor: Terumo BCT | Conditions: Sickle Cell Disease | NA | Status: COMPLETED | Results posted: 2014-07-14